Literature DB >> 11077268

Genetic analysis of mortality in murine angiostrongyliasis costaricensis using SMXA recombinant inbred mouse strains.

A Ishih1, T Ohno, M Nishimura, M Terada.   

Abstract

The SMXA recombinant inbred mouse strain set was produced by systematic inbreeding from the F2 generation of a cross between two progenitor inbred strains, A/J and SM/J, which differed markedly with respect to the patterns of infection with Angiostrongylus costaricensis. We have applied this set to genetic analysis of mouse susceptibility to this nematode infection. The mortality was variable among substrains of the SMXA RI strains, indicating the involvement of multiple genes. Linkage analysis showed several chromosomal regions closely linked to mortality; chromosome 6 (D6Rik86, 87; P<==0.001), 10 (D10Rik66-D10Mit12; P=0.0058), 13 (D13Rik79, 80; P=0.0096) and 17 (D17Mit28-D17Rik76; P=0.0088).

Entities:  

Mesh:

Year:  2000        PMID: 11077268     DOI: 10.1016/s1383-5769(00)00050-7

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  3 in total

1.  Establishment of consomic strains derived from A/J and SM/J mice for genetic analysis of complex traits.

Authors:  Tamio Ohno; Keiko Hata; Taisuke Baba; Fusayo Io; Misato Kobayashi; Fumihiko Horio; Masahiko Nishimura
Journal:  Mamm Genome       Date:  2012-10-10       Impact factor: 2.957

2.  Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortality.

Authors:  S M Geiger; W H Hoffmann; P T Soboslay; A W Pfaff; C Graeff-Teixeira; H Schulz-Key
Journal:  Parasitol Res       Date:  2003-05-16       Impact factor: 2.289

3.  Detection of loci for allergic asthma using SMXA recombinant inbred strains of mice.

Authors:  Tamio Ohno; Masakazu Okamoto; Toru Hara; Naozumi Hashimoto; Kazuyoshi Imaizumi; Miyoko Matsushima; Masahiko Nishimura; Kaoru Shimokata; Yoshinori Hasegawa; Tsutomu Kawabe
Journal:  Immunogenetics       Date:  2012-10-19       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.